Manorama Industries: A Sweet Ascent in Specialty Fats and Butters

Manorama Industries Limited, a global pioneer in specialty fats and butters, has reported a robust performance for the third quarter and nine months ended December 31, 2025. The company, known for its Cocoa Butter Equivalents (CBE) and exotic products, showcased significant growth, driven by strategic initiatives and strong market demand. For Q3 FY26, Manorama's revenue soared by 73.3% year-on-year to INR 362.5 crores. This impressive top-line growth translated into a 78.0% increase in EBITDA, reaching INR 98.2 crores, and a remarkable 131.1% surge in Profit After Tax (PAT) to INR 68.2 crores. The nine-month period also reflected this momentum, with revenues climbing 81.3% to INR 975.4 crores, EBITDA growing 108.3% to INR 264.9 crores, and PAT expanding 148.9% to INR 173.7 crores.

This stellar performance is attributed to an enhanced mix of value-added products, optimized utilization of their newly upgraded fractionation facility, and sustained demand from the chocolate, confectionery, and cosmetic sectors worldwide. The management has expressed strong confidence in this trajectory, revising its FY26 revenue guidance upwards from INR 1,150 crores to over INR 1,300 crores. This revision underscores the company's belief in its robust business model and strategic direction.

Financial Highlights at a Glance

Strategic Expansion and Market Leadership

Manorama Industries is not resting on its laurels. To meet the escalating demand for specialty fats and butters, the company is embarking on a significant capital expenditure plan of approximately INR 460 crores over the next 2-3 years. This investment includes several key projects:

1. Forward Integration for Cocoa Butter Alternative (CBA): A new manufacturing facility in India with a capacity of 75,000 MTPA.
2. New Solvent Fractionation Facility: A facility in India for Sal, Shea, Palm, Mango, and other exotic seeds, including ESOS, with a capacity of 75,000 MTPA.
3. New Refinery Manufacturing Facility: A 90,000 MTPA refinery in India.
4. Backward Integration in Burkina Faso: A processing factory in Africa with a capacity of 90,000 MTPA.

These expansions are designed to increase the company's existing fractionation capacity by 30% through debottlenecking, targeting 52,000 MTPA by the end of FY26. The company has already acquired 19.40 acres of new land and commissioned a new packing plant and laboratory building, funded through internal accruals. This strategic approach, coupled with an integrated value chain, provides Manorama with unparalleled control over quality, cost, and supply stability, reinforcing its position as a trusted partner in the chocolate, confectionery, and cosmetic industries.

Manorama's competitive edge is further sharpened by its deep backward integration, which ensures superior control over quality and cost efficiency. The company's R&D capabilities, including its DSIR-certified Milcoa® Innovation & Research Center, enable the development of customized products and act as a strong entry barrier. The company's diverse clientele, including Fortune 500 companies, highlights its strong market presence and customer stickiness.

Global Reach and Sustainable Practices

Manorama Industries is actively expanding its geographical footprint and strengthening its global presence. The company has six subsidiaries in Africa to bolster Shea seed sourcing and has established subsidiaries in UAE and Brazil to enhance procurement and onboard new customers in the MENA and Latin American regions. A notable partnership with DEKEL Agroindustria in Brazil marks Manorama as the first global CBE producer to manufacture in Brazil, with commercial production commencing in Q3 FY26.

Beyond financial growth, Manorama is deeply committed to sustainable business practices. Its 'Waste to Wealth' model empowers tribal women through seed collection, contributing to both economic upliftment and environmental conservation. The company adheres to a 'No Deforestation, No Peat, No Exploitation' policy and is involved in initiatives like the 'VANSAKHI' program for forest conservation. Manorama's dedication to ESG principles is further evidenced by its numerous global certifications, including RSPO, HALAL, ORGANIC, and FSSC 22000, and its recognition with the India CSR Award 2025 for its healthcare initiatives.

Outlook and Investor Confidence

Manorama Industries' Q3 and 9M FY26 results underscore a period of robust growth, strategic expansion, and operational excellence. The management's proactive approach to capacity building, market diversification, and sustainable practices positions the company for continued success. With a strong balance sheet, disciplined capital allocation, and a clear vision for leveraging industry tailwinds, Manorama Industries is well-equipped to deliver sustainable growth and value for its stakeholders in the years to come.